{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T06:35:24Z","timestamp":1792650924785,"version":"4.5.0"},"reference-count":21,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2021,3,26]],"date-time":"2021-03-26T00:00:00Z","timestamp":1616716800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK105845"],"award-info":[{"award-number":["DK105845"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CA205096"],"award-info":[{"award-number":["CA205096"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>Alcoholic liver disease (ALD) is responsible for an average of 50.4% and 44.2%of liver disease deaths among males and females respectively. Driven by alcohol misuse, ALD is often reversible by cessation of consumption. However, abstinence programs can have limited success at curtailing abuse, and the loss of life. ALD, therefore, remains a significant clinical challenge. There is a need for effective treatments that prevent or reverse alcohol-induced liver damage to complement or supplant behavioral interventions. Metabolic syndrome, which is disproportionally prevalent in ALD patients, accelerates the progression of ALD and increases liver disease mortality. Current rodent models of ALD unfortunately do not account for the contribution of the western diet to ALD pathology. To address this, we have developed a rodent model of ALD that integrates the impact of the western diet and alcohol; the WASH-diet model. We show here that the WASH diet, either chronically or in small time-restricted bouts, accelerated ALD pathology with severe steatohepatitis, elevated inflammation and increased fibrosis compared to mice receiving chronic alcohol alone. We also validated our WASH-diet model as an in vivo system for testing the efficacy of experimental ALD treatments. The efficacy of the inverse-agonist SR9238, previously shown to inhibit both non-alcohol and alcohol-induced steatohepatitis progression, was conserved in our WASH-diet model. These findings suggested that the WASH-diet may be useful for in vivo pre-clinical assessment of novel therapies.<\/jats:p>","DOI":"10.1371\/journal.pone.0249316","type":"journal-article","created":{"date-parts":[[2021,3,26]],"date-time":"2021-03-26T17:35:14Z","timestamp":1616780114000},"page":"e0249316","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":17,"title":["A two-hit model of alcoholic liver disease that exhibits rapid, severe fibrosis"],"prefix":"10.1371","volume":"16","author":[{"given":"Monideepa","family":"Sengupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suomia","family":"Abuirqeba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amina","family":"Kameric","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurore","family":"Cecile-Valfort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2990-6389","authenticated-orcid":true,"given":"Arindam","family":"Chatterjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristine","family":"Griffett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas P.","family":"Burris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5391-715X","authenticated-orcid":true,"given":"Colin A.","family":"Flaveny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2021,3,26]]},"reference":[{"key":"pone.0249316.ref001","unstructured":"Report\u2014Alcohol-Attributable Fractions, US, Excessive Use. [cited 20 Nov 2020]. Available: https:\/\/nccd.cdc.gov\/DPH_ARDI\/Default\/Report.aspx?T=AAF&P=1A04A664-0244-42C1-91DE-316F3AF6B447&R=B885BD06-13DF-45CD-8DD8-AA6B178C4ECE&F=&D="},{"key":"pone.0249316.ref002","unstructured":"Publications | National Institute on Alcohol Abuse and Alcoholism | Surveillance Report #113. [cited 20 Nov 2020]. Available: https:\/\/pubs.niaaa.nih.gov\/publications\/surveillance113\/CONS17.htm"},{"key":"pone.0249316.ref003","first-page":"2","article-title":"Alcoholic liver disease: Update on the role of dietary fat. Biomolecules.","author":"IA Kirpich","year":"2016","journal-title":"MDPI AG"},{"key":"pone.0249316.ref004","first-page":"157","volume-title":"Clinics in Liver Disease.","author":"DJ Chiang","year":"2014"},{"key":"pone.0249316.ref005","first-page":"586","volume-title":"Clinical and Molecular Hepatology.","author":"S Hwang","year":"2020"},{"key":"pone.0249316.ref006","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1002\/hep.27921","article-title":"Short- or long-term high-fat diet feeding plus acute ethanol binge synergistically induce acute liver injury in mice: An important role for CXCL1","volume":"62","author":"B Chang","year":"2015","journal-title":"Hepatology"},{"key":"pone.0249316.ref007","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jhep.2013.08.011","article-title":"Hepatocellular cancer: The impact of obesity, type 2 diabetes and a multidisciplinary team","volume":"60","author":"J Dyson","year":"2014","journal-title":"J Hepatol"},{"key":"pone.0249316.ref008","first-page":"1","volume-title":"Proceedings of the Nutrition Society","author":"DB Jump","year":"2016"},{"key":"pone.0249316.ref009","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1053\/jhep.2002.36780","article-title":"Risk factors for hepatocellular carcinoma: Synergism of alcohol with viral hepatitis and diabetes mellitus","volume":"36","author":"MM Hassan","year":"2002","journal-title":"Hepatology"},{"key":"pone.0249316.ref010","doi-asserted-by":"crossref","first-page":"G38","DOI":"10.1152\/ajpgi.00309.2012","article-title":"Ethanol administration exacerbates the abnormalities in hepatic lipid oxidation in genetically obese mice","volume":"304","author":"H Everitt","year":"2013","journal-title":"Am J Physiol\u2014Gastrointest Liver Physiol"},{"key":"pone.0249316.ref011","doi-asserted-by":"crossref","first-page":"e0191026","DOI":"10.1371\/journal.pone.0191026","article-title":"Light alcohol consumption has the potential to suppress hepatocellular injury and liver fibrosis in non-alcoholic fatty liver disease","volume":"13","author":"K Yamada","year":"2018","journal-title":"PLoS One"},{"key":"pone.0249316.ref012","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/nprot.2013.032","article-title":"Mouse model of chronic and binge ethanol feeding (the NIAAA model).","volume":"8","author":"A Bertola","year":"2013","journal-title":"Nat Protoc"},{"key":"pone.0249316.ref013","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1111\/acer.13840","article-title":"The Lieber-DeCarli Diet-A Flagship Model for Experimental Alcoholic Liver Disease","volume":"42","author":"F Guo","year":"2018","journal-title":"Alcohol Clin Exp Res"},{"key":"pone.0249316.ref014","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.alcohol.2012.08.004","article-title":"Rodent models of alcoholic liver disease: Of mice and men.","author":"E Brandon-Warner","year":"2012","journal-title":"Alcohol. Alcohol"},{"key":"pone.0249316.ref015","doi-asserted-by":"crossref","first-page":"e3152","DOI":"10.1038\/cddis.2017.532","article-title":"Inhibition of Caspase-8 does not protect from alcohol-induced liver apoptosis but alleviates alcoholic hepatic steatosis in mice","volume":"8","author":"F Hao","year":"2017","journal-title":"Cell Death Dis"},{"key":"pone.0249316.ref016","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1021\/acsptsci.8b00003","article-title":"Inhibition of Hepatotoxicity by a LXR Inverse Agonist in a Model of Alcoholic Liver Disease.","volume":"1","author":"M Sengupta","year":"2018","journal-title":"ACS Pharmacol Transl Sci"},{"key":"pone.0249316.ref017","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.molmet.2015.01.009","article-title":"The LXR inverse agonist SR9238 suppresses fibrosis in a model of non-alcoholic steatohepatitis","volume":"4","author":"K Griffett","year":"2015","journal-title":"Mol Metab"},{"key":"pone.0249316.ref018","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/hep.510250120","article-title":"Excess weight risk factor for alcoholic liver disease","volume":"25","author":"S Naveau","year":"1997","journal-title":"Hepatology"},{"key":"pone.0249316.ref019","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1136\/gut.2010.213553","article-title":"Components of metabolic syndrome are independent predictors of mortality in patients with chronic liver disease: A population-based study","volume":"59","author":"M Stepanova","year":"2010","journal-title":"Gut"},{"key":"pone.0249316.ref020","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1111\/j.1365-2036.2009.04141.x","article-title":"Synergistic association between alcohol intake and body mass index with serum alanine and aspartate aminotransferase levels in older adults: The Rancho Bernardo Study.","volume":"30","author":"R Loomba","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"pone.0249316.ref021","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1172\/JCI124376","article-title":"Brown fat activation mitigates alcohol-induced liver steatosis and injury in mice","volume":"129","author":"H Shen","year":"2019","journal-title":"J Clin Invest"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0249316","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,26]],"date-time":"2021-03-26T17:35:40Z","timestamp":1616780140000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0249316"}},"subtitle":[],"editor":[{"given":"Matias A.","family":"Avila","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,3,26]]},"references-count":21,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,3,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0249316","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,26]]}}}